Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation

Inclusion Criteria: * Patient has an end stage kidney disease and is a suitable candidate for primary renal transplantation or retransplantation * Patient is receiving a kidney transplant, from a cadaveric or living donor between 5 and 65 years of age with compatible ABO blood type Exclusion Criteria: * Patient has an immunological high risk, defined as having a most recently measured PRA grade of \>= 50% within the previous six months * Patient requires ongoing dosing with a systemic immunosuppressive drug at study entry for any reason other than kidney transplantation * Patient requires initial sequential or parallel therapy with immunosuppressive antibody preparation(s) * Patient or donor is known to be HIV positive * Patient with malignancy or history of malignancy, except non metastatic basal or squamous cell carcinoma of the skin that has been treated successfully * Patient has significant, uncontrolled concomitant infections and/or severe diarrhoea, vomiting, or active peptic ulcer * Patient is receiving a graft from a non-heart-beating donor * Cold ischemia time of the donor kidney \>= 40 hours